BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 15878643)

  • 1. Involvement of extracellular signal-regulated kinases 1/2 and (phosphoinositide 3-kinase)/Akt signal pathways in acquired resistance against neurotoxin of 6-hydroxydopamine in SH-SY5Y cells following cell-cell interaction with astrocytes.
    Jiang Z; Yu PH
    Neuroscience; 2005; 133(2):405-11. PubMed ID: 15878643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zinc-induced anti-apoptotic effects in SH-SY5Y neuroblastoma cells via the extracellular signal-regulated kinase 1/2.
    An WL; Pei JJ; Nishimura T; Winblad B; Cowburn RF
    Brain Res Mol Brain Res; 2005 Apr; 135(1-2):40-7. PubMed ID: 15857667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lonicera japonica THUNB. protects 6-hydroxydopamine-induced neurotoxicity by inhibiting activation of MAPKs, PI3K/Akt, and NF-κB in SH-SY5Y cells.
    Kwon SH; Hong SI; Jung YH; Kim MJ; Kim SY; Kim HC; Lee SY; Jang CG
    Food Chem Toxicol; 2012 Mar; 50(3-4):797-807. PubMed ID: 22227216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of Erk1/2 and Akt in astrocytes under ischemia.
    Jiang Z; Zhang Y; Chen X; Lam PY; Yang H; Xu Q; Yu AC
    Biochem Biophys Res Commun; 2002 Jun; 294(3):726-33. PubMed ID: 12056831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arylpiperazine-mediated activation of Akt protects SH-SY5Y neuroblastoma cells from 6-hydroxydopamine-induced apoptotic and autophagic death.
    Tovilovic G; Zogovic N; Soskic V; Schrattenholz A; Kostic-Rajacic S; Misirkic-Marjanovic M; Janjetovic K; Vucicevic L; Arsikin K; Harhaji-Trajkovic L; Trajkovic V
    Neuropharmacology; 2013 Sep; 72():224-35. PubMed ID: 23643751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in early and late responses between neurotrophin-stimulated trkA- and trkC-transfected SH-SY5Y neuroblastoma cells.
    Edsjö A; Hallberg B; Fagerström S; Larsson C; Axelson H; Påhlman S
    Cell Growth Differ; 2001 Jan; 12(1):39-50. PubMed ID: 11205744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreases in phosphoinositide-3-kinase/Akt and extracellular signal-regulated kinase 1/2 signaling activate components of spinal motoneuron death.
    Newbern J; Taylor A; Robinson M; Li L; Milligan CE
    J Neurochem; 2005 Sep; 94(6):1652-65. PubMed ID: 16045454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human intestinal epithelial crypt cell survival and death: Complex modulations of Bcl-2 homologs by Fak, PI3-K/Akt-1, MEK/Erk, and p38 signaling pathways.
    Harnois C; Demers MJ; Bouchard V; Vallée K; Gagné D; Fujita N; Tsuruo T; Vézina A; Beaulieu JF; Côté A; Vachon PH
    J Cell Physiol; 2004 Feb; 198(2):209-22. PubMed ID: 14603523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of ERK1/2, JNK and PKB by hydrogen peroxide in human SH-SY5Y neuroblastoma cells: role of ERK1/2 in H2O2-induced cell death.
    Ruffels J; Griffin M; Dickenson JM
    Eur J Pharmacol; 2004 Jan; 483(2-3):163-73. PubMed ID: 14729104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effect of creatine against 6-hydroxydopamine-induced cell death in human neuroblastoma SH-SY5Y cells: Involvement of intracellular signaling pathways.
    Cunha MP; Martín-de-Saavedra MD; Romero A; Parada E; Egea J; Del Barrio L; Rodrigues AL; López MG
    Neuroscience; 2013 May; 238():185-94. PubMed ID: 23485810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IGF-I receptor signaling pathway is involved in the neuroprotective effect of genistein in the neuroblastoma SK-N-SH cells.
    Gao QG; Xie JX; Wong MS; Chen WF
    Eur J Pharmacol; 2012 Feb; 677(1-3):39-46. PubMed ID: 22227334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of the effects of four mood stabilizers in SH-SY5Y cells and in primary neurons.
    Di Daniel E; Mudge AW; Maycox PR
    Bipolar Disord; 2005 Feb; 7(1):33-41. PubMed ID: 15654930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bcl-x L blocks mitochondrial multiple conductance channel activation and inhibits 6-OHDA-induced death in SH-SY5Y cells.
    Jordán J; Galindo MF; Tornero D; González-García C; Ceña V
    J Neurochem; 2004 Apr; 89(1):124-33. PubMed ID: 15030396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoflurane preconditioning protects human neuroblastoma SH-SY5Y cells against in vitro simulated ischemia-reperfusion through the activation of extracellular signal-regulated kinases pathway.
    Zuo Z; Wang Y; Huang Y
    Eur J Pharmacol; 2006 Aug; 542(1-3):84-91. PubMed ID: 16806162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caffeine activates the PI3K/Akt pathway and prevents apoptotic cell death in a Parkinson's disease model of SH-SY5Y cells.
    Nakaso K; Ito S; Nakashima K
    Neurosci Lett; 2008 Feb; 432(2):146-50. PubMed ID: 18201823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective effects of neurokinin receptor one in dopaminergic neurons are mediated through Akt/PKB cell signaling pathway.
    Chu JM; Chen LW; Chan YS; Yung KK
    Neuropharmacology; 2011 Dec; 61(8):1389-98. PubMed ID: 21907219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High K+ and IGF-1 protect cerebellar granule neurons via distinct signaling pathways.
    Zhong J; Deng J; Huang S; Yang X; Lee WH
    J Neurosci Res; 2004 Mar; 75(6):794-806. PubMed ID: 14994340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calbindin-D28K inhibits apoptosis in dopaminergic neurons by activation of the PI3-kinase-Akt signaling pathway.
    Sun S; Li F; Gao X; Zhu Y; Chen J; Zhu X; Yuan H; Gao D
    Neuroscience; 2011 Dec; 199():359-67. PubMed ID: 22020319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signal transduction pathways implicated in neural recognition molecule L1 triggered neuroprotection and neuritogenesis.
    Loers G; Chen S; Grumet M; Schachner M
    J Neurochem; 2005 Mar; 92(6):1463-76. PubMed ID: 15748164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HGF protects corneal epithelial cells from apoptosis by the PI-3K/Akt-1/Bad- but not the ERK1/2-mediated signaling pathway.
    Kakazu A; Chandrasekher G; Bazan HE
    Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3485-92. PubMed ID: 15452053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.